Tiotropium Reduces Risk of Exacerbations Irrespective of Previous Use of Inhaled Anticholinergics in Placebo-Controlled Clinical Trials

International Journal of COPD - New Zealand
doi 10.2147/copd.s17864
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Lumacaftor/Ivacaftor Reduces Pulmonary Exacerbations in Patients Irrespective of Initial Changes in FEV1

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2019English

PRS3 Inhaled Anticholinergics and Risk of All-Cause Mortality in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta Analysis of Randomized Controlled Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Inhaled Hypertonic Saline Reduces Pulmonary Exacerbations in Cystic Fibrosis

Thorax
PulmonaryRespiratory Medicine
2006English

Inhaled Corticosteroid Use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study

Lung
PulmonaryRespiratory Medicine
2017English

Dropout Rates in Placebo-Controlled and Active-Control Clinical Trials of Antipsychotic Drugs

Archives of General Psychiatry
2005English

Tiotropium Versus Placebo for Inadequately Controlled Asthma: A Meta-Analysis

Respiratory Care
MedicinePulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2013English

Placebo Response in Antipsychotic Clinical Trials

JAMA Psychiatry
MedicinePsychiatryMental Health
2014English

Use of Tiotropium Bromide in an Adolescent With Adrenal Suppression Secondary to Inhaled Mometasone Furoate

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy